Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;38(3):171-180.
doi: 10.1111/omi.12408. Epub 2023 Mar 3.

Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials

Filippo D'Amico  1 , Matteo Moro  2 , Marco Saracino  1 , Marilena Marmiere  1 , Maria Bernadette Cilona  3 , Graham Lloyd-Jones  4 , Alberto Zangrillo  1   5
Affiliations

Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials

Filippo D'Amico et al. Mol Oral Microbiol. 2023 Jun.

Abstract

Introduction: COVID-19 is a transmissible respiratory and multisystem disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Viral transmission occurs mainly through the spread of salivary droplets or aerosol from an infected subject. Studies suggest that salivary viral load is correlated with disease severity and probability of transmission. Cetylpyridinium chloride mouthwash has been found to be effective in reducing salivary viral load. The aim of this systematic review of randomized controlled trials is to evaluate the efficacy of the mouthwash ingredient cetylpyridinium chloride on salivary viral load in SARS-CoV-2 infection.

Methods: Randomized controlled trials comparing cetylpyridinium chloride mouthwash with placebo and other mouthwash ingredients in SARS-CoV-2 positive individuals were identified and evaluated.

Results: Six studies with a total of 301 patients that met the inclusion criteria were included. The studies reported the efficacy of cetylpyridinium chloride mouthwashes in reduction on SARS-CoV-2 salivary viral load compared to placebo and other mouthwash ingredients.

Conclusion: Mouthwashes containing cetylpyridinium chloride are effective against salivary viral load of SARS-CoV-2 in vivo. There is also the possibility that the use of mouthwash containing cetylpyridinium chloride in SARS-CoV-2 positive subjects could reduce transmissibility and severity of COVID-19.

Keywords: COVID-19; CPC; SARS-CoV-2; cetylpyridinium chloride; mouthwash; salivary viral load.

PubMed Disclaimer

References

REFERENCES

    1. Alemany, A., Perez-Zsolt, D., Raïch-Regué, D., Muñoz-Basagoiti, J., Ouchi, D., Laporte-Villar, C., Baro, B., Henríquez, N., Prat, N., Gianinetto, M. O, Gutiérrez, M. V, Sánchez-Paniagua, M. G, Henríquez, N. L, Vicente, J. M, Ara, J., Rodriguez-Arias, M. A., Puig, J., Blanco, I., Lopez, C. C, … Mitjà, O. (2022). Cetylpyridinium chloride mouthwash to reduce shedding of infectious SARS-CoV-2: A double-blind randomized clinical trial. Journal of Dental Research, 101, 1450-1456. https://doi.org/10.1177/00220345221102310
    1. Alvarez, D. M., Duarte, L. F., Corrales, N., Smith, P. C., & González, P. A. (2020). Cetylpyridinium chloride blocks herpes simplex virus replication in gingival fibroblasts. Antiviral Research, 179, 104818. https://doi.org/10.1016/j.antiviral.2020.104818
    1. Aydin, S., Benk, I. G., & Geckil, A. A. (2021). May viral load detected in saliva in the early stages of infection be a prognostic indicator in COVID-19 patients? Journal of Virological Methods, 294, 114198. https://doi.org/10.1016/j.jviromet.2021.114198
    1. Baghizadeh Fini, M. (2020). Oral saliva and COVID-19. Oral Oncology, 108, 104821.
    1. Barrueco, S. Á., Mateos-Moreno, M. V., Martínez-Beneyto, Y., García-Vázquez, E., Campos González, A., Zapardiel Ferrero, J., Bogoya Castaño, A., Alcalá Rueda, I., Villacampa Aubá, J. M., Cenjor Español, C., Moreno-Parrado, L., Ausina-Márquez, V., García-Esteban, S., Artacho, A., López-Labrador, F. X., Mira, A., & Ferrer, M. D. (2022). Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: Evidence from a randomized double-blind clinical trial. Emerging Microbes & Infections, 11(1), 1833-1842. https://doi.org/10.1080/22221751.2022.2098059

Publication types

LinkOut - more resources